Literature DB >> 25285

Coordinacy of lysosomal enzyme excretion in human urine.

K Paigen, J Peterson.   

Abstract

Assay conditions have been developed for the determination of urinary beta-glucuronidase, beta-galactosidase, alpha-galactosidase, and beta-hexosaminidase using fluorometric substrates. The assay conditions for beta-glucuronidase overcome interference by both low and high molecular weight inhibitors, a problem that has confused earlier studies of enzyme excretion. The four lysosomal enzymes are excreted corrdinately: although their absolute levels (in units per milligram of creatinine) vary during the day and from one day to the next, the ratio of one enzyme to another remains relatively constant. The lack of correlation betweem plasma and urine enzyme levels, together with the high molecular weights of these enzymes, suggests that the urinary enzymes are not derived by glomerular filtration. The lack of coordinacy with lactate dehydrogenase suggests they are not derived from exfoliated cells. by analogy with experimental animals, they may be derived from lysosomes extruded into the lumen of the proximal tubule by epithelial cells. There is considerable variation among a population of 125 healthy adult subjects for total enzyme excretion. Both total enzyme excretion and coordinacy ratios are log-normally distributed, suggesting that they are the resultants of many factors, each of which has a relative, or proportional, effect on enzyme excretion. About one-half the population variation resides in a process common to the excretion of all four enzymes (possibly the lysosome extrusion pathway), and about one-half resides in factors affecting each enzyme independently.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 25285      PMCID: PMC372590          DOI: 10.1172/JCI108989

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  39 in total

1.  Lack of relationship between blood and urine levels of glycosaminoglycans and lysomal enzymes.

Authors:  R P Erickson; R Sandman; C J Epstein
Journal:  Biochem Med       Date:  1975-04

2.  The molecular genetics of mammalian glucuronidase.

Authors:  K Paigen; R T Swank; S Tomino; R E Ganschow
Journal:  J Cell Physiol       Date:  1975-04       Impact factor: 6.384

3.  PREPUTIAL GLAND BETA-GLUCURONIDASE RESPONSE TO TESTOSTERONE AND TO TWO ANABOLIC STEROIDS.

Authors:  J F PATTERSON; M CHENEY; W H FISHMAN
Journal:  Endocrinology       Date:  1964-08       Impact factor: 4.736

4.  Biochemical factors in the etiology of carcinoma of the bladder. The role of beta-glucuronidase.

Authors:  W K KERR; M BARKIN; J D'ALOISIO
Journal:  Cancer       Date:  1963-05       Impact factor: 6.860

5.  Symposium on azotemia.

Authors:  R P MACFATE; C COHN; L EICHELBERGER; J A COOPER
Journal:  Am J Clin Pathol       Date:  1954-05       Impact factor: 2.493

6.  X-linked inheritance of a structural gene for alpha-galactosidase in Mus musculus.

Authors:  A J Lusis; J D West
Journal:  Biochem Genet       Date:  1976-10       Impact factor: 1.890

7.  The Chediak-Higashi (beige) mutation in two mouse strains. Allelism and similarity in lysosomal dysfunction.

Authors:  E J Brandt; R T Swank
Journal:  Am J Pathol       Date:  1976-03       Impact factor: 4.307

8.  Genetic determination of the beta-galactosidase developmental program in mouse liver.

Authors:  K Paigen; M Meisler; J Felton; V Chapman
Journal:  Cell       Date:  1976-12       Impact factor: 41.582

9.  THE CYTOLOGIC DEMONSTRATION OF BETA-GLUCURONIDASE EMPLOYING NAPHTHOL AS-BI GLUCURONIDE AND HEXAZONIUM PARAROSANILIN; A PRELIMINARY REPORT.

Authors:  M HAYASHI; Y NAKAJIMA; W H FISHMAN
Journal:  J Histochem Cytochem       Date:  1964-04       Impact factor: 2.479

10.  Enzyme activity in relation to cancer; the urinary beta-glucuronidase activity of patients suffering from malignant disease.

Authors:  E BOYLAND; J E GASSON; D C WILLIAMS
Journal:  Br J Cancer       Date:  1957-03       Impact factor: 7.640

View more
  13 in total

1.  Irreversible tubulointerstitial damage associated with chronic aminonucleoside nephrosis. Amelioration by angiotensin I converting enzyme inhibition.

Authors:  J R Diamond; S Anderson
Journal:  Am J Pathol       Date:  1990-12       Impact factor: 4.307

2.  Lysosomal enzymes in biological fluids: physiologic and pathophysiologic significance.

Authors:  N F LaRusso
Journal:  Dig Dis Sci       Date:  1979-03       Impact factor: 3.199

3.  A genetic component in human lysosomal enzyme excretion.

Authors:  K Paigen; J Peterson; E Ward
Journal:  Biochem Genet       Date:  1984-06       Impact factor: 1.890

4.  Correlation between urinary activity of N-acetyl-beta-D-glucosaminidase (NAG) and albumin excretion rate in type II (non-insulin-dependent) diabetic subjects.

Authors:  G Perdichizzi; D Cucinotta; R Fera; E Di Cesare; S Campo; G Squadrito
Journal:  Acta Diabetol Lat       Date:  1987 Apr-Jun

5.  alpha-Glucosidase and N-acetylglucosamine-6-sulphatase are the major mannose-6-phosphate glycoproteins in human urine.

Authors:  D E Sleat; S R Kraus; I Sohar; H Lackland; P Lobel
Journal:  Biochem J       Date:  1997-05-15       Impact factor: 3.857

6.  Coordinate secretion of acid hydrolases in rat bile.

Authors:  N F LaRusso; S Fowler
Journal:  J Clin Invest       Date:  1979-10       Impact factor: 14.808

7.  NAG, GGT, creatinine, urea and creatinine clearance before and after ESWL.

Authors:  O Erkizan; A R Ayder; S Minareci; M Lekili; C Dincel
Journal:  Int Urol Nephrol       Date:  1994       Impact factor: 2.370

8.  Serum and urinary activities of beta-N-acetylglucosaminidase and beta-glucuronidase in diabetic patients.

Authors:  G Perdichizzi; D Cucinotta; A Saitta; A Cavalieri; G Squadrito
Journal:  Acta Diabetol Lat       Date:  1983 Jul-Sep

9.  Serum activity of beta-N-acetylglucosaminidase in obese hyperinsulinemic subjects.

Authors:  G Perdichizzi; D Cucinotta; A Saitta; G Squadrito
Journal:  Acta Diabetol Lat       Date:  1985 Jul-Sep

10.  Association between pulse wave velocity and a marker of renal tubular damage (N-acetyl-β-D-glucosaminidase) in patients without diabetes.

Authors:  Motoshi Ouchi; Kenzo Oba; Taro Saigusa; Kentaro Watanabe; Makoto Ohara; Noriaki Matsumura; Tatsuya Suzuki; Naohiko Anzai; Shuichi Tsuruoka; Masahiro Yasutake
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-02-09       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.